M
Michael Odida
Researcher at Makerere University
Publications - 19
Citations - 2319
Michael Odida is an academic researcher from Makerere University. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 9, co-authored 14 publications receiving 2015 citations.
Papers
More filters
Journal ArticleDOI
Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
Silvia de Sanjosé,Wim Quint,Laia Alemany,D.T. Geraets,Jo Ellen Klaustermeier,Belen Lloveras,Sara Tous,Ana Félix,Luis Eduardo Bravo,Hai Rim Shin,Carlos S. Vallejos,Patricia Alonso de Ruiz,Marcus Aurelho Lima,Núria Guimerà,Omar Clavero,Maria Alejo,Antonio Llombart-Bosch,Chou Cheng-Yang,Silvio Tatti,Elena Kasamatsu,Ermina Iljazovic,Michael Odida,Rodrigo Prado,Muhieddine Seoud,Magdalena Grce,Alp Usubutun,Asha Jain,Gustavo Adolfo Hernandez Suarez,Luis Estuardo Lombardi,Aekunbiola Banjo,Clara Menendez,Efren J. Domingo,Julio Velasco,Ashrafun Nessa,Saibua Chichareon,You-Lin Qiao,Enrique Lerma,Suzanne M. Garland,Toshiyuki Sasagawa,Annabelle Ferrera,Doudja Hammouda,Luciano Mariani,Adela Pelayo,Ivo Šteiner,Esther Oliva,Chris J. L. M. Meijer,Waleed Al-Jassar,Eugenia Cruz,Thomas C. Wright,Ana Puras,Cecilia L. Llave,Maria Tzardi,Theodoros Agorastos,Victoria Garcia-Barriola,Christine Clavel,Jaume Ordi,Miguel Andújar,Xavier Castellsagué,Gloria I. Sanchez,Andrzej Nowakowski,Jacob Bornstein,Nubia Muñoz,F. Xavier Bosch +62 more
TL;DR: HPV types 16, 18, 31, 33, 35, 45, 52, and 58 should be given priority when the cross-protective effects of current vaccines are assessed, and for formulation of recommendations for the use of second-generation polyvalent HPV vaccines, according to this largest assessment of HPV genotypes to date.
Journal ArticleDOI
Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
Cathy Ndiaye,Laia Alemany,Nafissatou Ndiaye,Bakarou Kamate,Yankhoba Diop,Michael Odida,Kunbi Banjo,Sara Tous,Jo Ellen Klaustermeier,Omar Clavero,Xavier Castellsagué,F. Xavier Bosch,Helen Trottier,Silvia de Sanjosé +13 more
TL;DR: To describe human papillomavirus distribution in invasive cervical carcinoma from Mali and Senegal and to compare type‐specific relative contribution among sub‐Saharan African countries is compared.
Journal ArticleDOI
Factors associated with carcinoma of the oesophagus at Mulago Hospital, Uganda.
Ponsiano Ocama,Magid Kagimu,Michael Odida,Henry Wabinga,Christopher Kenneth Opio,Britt Colebunders,Sabrina van Ierssel,Robert Colebunders +7 more
TL;DR: Many patients referred for EGD in Uganda had esophageal cancer most of which were smoking, male gender and older age were risk factors, and Preventive measures should target stopping smoking.
Journal ArticleDOI
Agreement between diagnoses of childhood lymphoma assigned in Uganda and by an international reference laboratory
Jackson Orem,Sven Sandin,Caroline E. Weibull,Michael Odida,Henry Wabinga,Edward Mbidde,Fred Wabwire-Mangen,Chris J.L.M. Meijer,Jaap M. Middeldorp,Elisabete Weiderpass +9 more
TL;DR: Clinical diagnosis of NHL in Uganda has a high probability of error compared with pathological diagnosis in Uganda and in The Netherlands, and agreement on the pathological diagnosis between Uganda and The Netherlands is very low.
Journal ArticleDOI
Grade of malignancy of cervical cancer in regions of Uganda with varying malarial endemicity
TL;DR: In a prior study on malignant lymphomas, 3 and 6 areas of Uganda showing low and high malarial endemicity, respectively, were selected for analysis and the data retrieved from the Kampala Cancer Registry, which in the 1960s and 1970s collected cases of cancer through a widely used free biopsy service from the whole country as mentioned in this paper.